Skip to main content
Fig. 2 | BMC Immunology

Fig. 2

From: Membrane tension sensing molecule-FNBP1 is a prognostic biomarker related to immune infiltration in BRCA, LUAD and STAD

Fig. 2

Survival Curves of high and low expression of FNBP1 in different cancers from the PrognoScan. A OS (n = 77) in brain cancer cohort GSE4271-GPL96. B OS (n = 74) in brain cancer cohort GSE4412-GPL96. C RFS (n = 87) in breast cancer cohort GSE6532-GPL570. D DMFS (n = 87) in breast cancer cohort GSE6532-GPL570. E OS (n = 159) in breast cancer cohort GSE1456-GPL96. F DSS (n = 159) in breast cancer cohort GSE1456-GPL96. G RFS (n = 159) in breast cancer cohort GSE1456-GPL97. H DMFS (n = 286) in breast cancer cohort GSE2034. I RFS (n = 77) in breast cancer cohort GSE9195. J DMFS (n = 77) in breast cancer cohort GSE9195. K DMFS (n = 200) in breast cancer cohort GSE11121. L DFS (n = 76) in breast cancer cohort GSE7849. M DSS (n = 236) in breast cancer cohort GSE3494-GPL96. N DFS (n = 249) in breast cancer cohort GSE4922-GPL97. O OS (n = 180) in blood cancer cohort GSE16131-GPL96. P DSS (n = 559) in blood cancer cohort GSE2658. Q OS (n = 55) in colorectal cancer cohort GSE17537. R RFS (n = 204) in lung cancer cohort GSE31210. S OS (n = 133) in ovarian cancer cohort DUKE-OC. T OS (n = 38) in skin cancer cohort GSE19234. OS, overall survival; DMFS, distant metastasis-free survival; DFS, disease-free survival; RFS, relapse-free survival

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us